Well said. I was thinking the same about the CR. IMO it wasn't a mistake it had to happen and was just a matter of when. There was never going to be a good time, it was strategic and the best time that it could happen. All over and now not thinking about funding just getting through trials - hopefully with amazing results.
I'm glad they did it when they did instead of leaving it. It would be getting funded at 6c or 7c if they'd left it!
Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-56
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
